Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

2.3K
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
2.3K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

414
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
414
Imaging Studies VII: Vascular Imaging01:19

Imaging Studies VII: Vascular Imaging

558
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
558
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

559
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
559
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

527
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
527
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

679
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
679

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pre-existing anxiety and mood disorders and multisystem outcomes in young adults with chronic kidney disease.

Clinical kidney journal·2026
Same author

Atlas of glomerular disease-specific genetic effects on blood transcriptome.

medRxiv : the preprint server for health sciences·2026
Same author

Prospective Study of Multiparametric Renal MRI for CKD Progression (AFiRM).

Kidney international reports·2026
Same author

From Genes to Membrane Failure: Genetic Determinants of Peritoneal Dialysis Physiology and Outcomes.

Genes·2026
Same author

The impact of multiple long-term conditions on mortality, progression to kidney failure and health-related quality of life among people with chronic kidney disease: a multicentre cohort study (NURTuRE-CKD).

Annals of medicine·2026
Same author

CKM Multimorbidity Burden and Phenotype Differentially Influence Cardiovascular and Renal Risk in Advanced CKD.

Cardiorenal medicine·2026

Related Experiment Video

Updated: May 2, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

7.3K

Revascularization as a treatment to improve renal function.

Helen V Alderson1, James P Ritchie1, Philip A Kalra1

  • 1The University of Manchester, Manchester Academic Health Sciences Centre, Vascular Research Group, Department of Renal Medicine, Salford Royal NHS Foundation Trust, Salford, UK.

International Journal of Nephrology and Renovascular Disease
|March 7, 2014
PubMed
Summary
This summary is machine-generated.

Atherosclerotic renovascular disease (ARVD) is increasing. This review examines current evidence on managing ARVD, focusing on revascularization to improve kidney function, despite inconsistent trial results.

Keywords:
atherosclerotic renovascular diseasefibromuscular dysplasiarenal artery stenosisrevascularization

More Related Videos

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.6K
Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
12:27

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration

Published on: June 7, 2014

50.1K

Related Experiment Videos

Last Updated: May 2, 2026

Intravascular Delivery of Biologics to the Rat Kidney
07:29

Intravascular Delivery of Biologics to the Rat Kidney

Published on: September 1, 2016

7.3K
Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

3.6K
Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration
12:27

Renal Ischaemia Reperfusion Injury: A Mouse Model of Injury and Regeneration

Published on: June 7, 2014

50.1K

Area of Science:

  • Cardiology
  • Nephrology
  • Vascular Surgery

Background:

  • Atherosclerotic renovascular disease (ARVD) prevalence is rising due to an aging population.
  • Medical management for atherosclerotic conditions has advanced.
  • Endovascular revascularization is available but lacks consistent evidence of benefit for ARVD.

Purpose of the Study:

  • To review the current evidence for managing ARVD.
  • To focus on revascularization as a treatment to improve renal function.
  • To provide an overview of ARVD's impact on kidney function.

Main Methods:

  • Review of published randomized controlled trials and existing literature on ARVD.
  • Analysis of evidence for revascularization in ARVD and other renal artery stenosis causes.
  • Synthesis of current best practices in ARVD patient management.

Main Results:

  • Inconsistent evidence exists regarding the benefits of endovascular revascularization in ARVD.
  • There is no clear consensus on patient selection for revascularization procedures.
  • Published trials offer varying clarity and success in guiding best practice.

Conclusions:

  • Further research and clearer guidelines are needed for optimal ARVD management.
  • Patient selection for revascularization remains a critical challenge.
  • Revascularization's role in improving renal function in ARVD requires more definitive evidence.